CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Option exercise Chief Commercial Officer acquired 26,482 shares (option exercise)
- 4 Option exercise See Remarks acquired 13,042 shares (option exercise)
- 4 Option exercise President/CEO and Board Chair acquired 66,274 shares (option exercise)
- 4 Option exercise Chief Medical Officer acquired 2,511 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Operating Officer sold 8,366 shares at $76.67 ($641,421)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 2,233 shares (option exercise)
- 4 Planned sale Chief Human Resources Officer sold 15,565 shares at an average $80.67 ($1,255,684)
- 4 Planned sale President/CEO and Board Chair sold 6,000 shares at an average $82.51 ($495,089)
- 4 Gift Chief Operating Officer gave 950 shares (gift)
- 4 Planned sale Chief Human Resources Officer sold 7,397 shares at $80.10 ($592,500)
- 4 Planned sale Director sold 22,946 shares at an average $81.26 ($1,864,678)
Page 3 of 17 · 330 filings